rdESAT-6 and rCFP-10 (Cy-Tb) Injection (Detection of Latent-tuberculosis)

Vaccine Overview

This diagnostic injection is used for detecting latent tuberculosis infection. It contains recombinant TB-specific antigens ESAT-6 and CFP-10, which are absent in BCG and most non-tuberculous mycobacteria. Injected intradermally, it triggers a local immune response in TB-infected individuals, allowing for accurate detection without false positives from BCG vaccination. It is an alternative to traditional tuberculin skin tests and is useful for screening high-risk populations, healthcare workers, and close contacts of TB patients.

Drug Class: Human Diagnostics

Indication: Detection of latent tuberculosis infection using specific antigens absent in BCG and NTM strains.

PREVENTS

Latent Tuberculosis

Vaccine Details

Applied To

Infants, Children

Recommended Time

TB screening in high-risk or exposed individuals

Administration

Route: Intradermal

Site: Forearm (similar to tuberculin skin test site)

Disease

Latent Tuberculosis

Manufacturer

Serum Intitute Of India

Age

≥5 years (varies by country)

Disclaimer

This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.

Last updated: May 2, 2025